Skip to main content
Premium Trial:

Request an Annual Quote

Allscripts' 2bPrecise to Provide NIH With Cloud-Based Software for Precision Medicine

NEW YORK (GenomeWeb) – 2bPrecise, a wholly owned subsidiary of Allscripts Healthcare, said today that it has launched an early-adopter program at the National Institutes of Health for its cloud-based genomics and precision medicine solution.

According to 2bPrecise, its cloud-based software uses advanced clinical-genomic ontology and data harmonization methods to combine genomic, clinical, and lifestyle information. The solution simplifies and optimizes the process of finding, selecting, ordering, and receiving genomic tests and it integrates with Allscripts' Sunrise Electronic Health Record system and other EHR systems enabling clinicians to use the results of sequencing tests at the point of care, 2bPrecise said.

Under the terms of the agreement, physicians and researchers at the National Human Genome Research Institute, the National Cancer Institute, and the NIH Clinical Center will use 2bPrecise's solution to improve patient diagnosis and advance medical research. Moving forward, the company intends to make the software broadly available to provider, integrated delivery network, and payer organizations who want "to advance the research that will unlock new insights of molecular diagnostics and new treatments," 2bPrecise General Manager Assaf Halevy said in a statement.

Financial and other terms of the agreement were not disclosed. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.